Emerging applications and regulatory strategies for advanced medicines manufacturing - towards the development of a platform approach

Jagjit Singh Srai, Paul Bauer, Clive Badman, Massimo Bresciani, Charles L. Cooney, Alastair Florence, Doug Hausner, Konstantin Konstantinov, Sau L Lee, Salvatore Mascia, Moheb Nasr, Bernhardt L Trout

Research output: Contribution to journalArticlepeer-review

Abstract

The last decade has seen Advanced Medicines Manufacturing (AMM) progress from isolated product developments to the creation of industry-academic centres of excellence, regulatory innovation progressing leading to new standards, and product commercialisation across multiple product formats. This paper examines these developments focusing on successful applications and strategies presented at the 2023 Symposium of the International Consortium for Advanced Medicines Manufacturing (ICAMM). Despite these exemplar applications, there remain significant challenges to the sector-wide adoption of AMM technologies. Drawing on Symposium delegate expert responses to open-ended questions, our coding-based thematic analysis suggest three primary enablers drive successful adoption of AMM technologies at scale, namely: the ability to leverage pre-competitive collaborations to challenge-based problem solving; information and knowledge sharing through centres of excellence; and the development of AMM specific regulatory standards. Further analysis of expert responses identified the emergence of a 'Platform creation' approach to AMM innovation; characterised by: i) New collaboration modes; ii) Exploration of common product-process platforms for new dosage forms and therapy areas; iii) Development of modular equipment assets that enable scale-out, and offer more decentralized or distributed manufacturing models; iv) Standards based on product-process platform archetypes; v) Implementation strategies where platform-thinking and AMM technologies can significantly reduce timelines between discovery, approval and GMP readiness. We provide a definition of the Platform creation concept for AMM and discuss the requirements for its systematic development. [Abstract copyright: Copyright © 2024 American Pharmacists Association. All rights reserved.]
Original languageEnglish
JournalJournal of Pharmaceutical Sciences
Early online date23 Apr 2024
DOIs
Publication statusE-pub ahead of print - 23 Apr 2024

Keywords

  • Supply chain
  • Platform
  • Advanced medicines manufacturing
  • Continuous processing

Fingerprint

Dive into the research topics of 'Emerging applications and regulatory strategies for advanced medicines manufacturing - towards the development of a platform approach'. Together they form a unique fingerprint.

Cite this